Two randomized , placebo-controlled trials were performed with @ flavivirus-naive adults to demonstrate the safety and immunogenicity of a live attenuated tetravalent dengue vaccine ( TV@ ) , compared with those of a second tetravalent vaccine with an enhanced DENV-@ component ( TV@ ) , and to evaluate the benefit of a booster dose at @ months .